Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
10612studies shown
Showing 2,533-2,544 of 10,612
Drug study icon
CompletedNCT04115319

Safety study of investigational Drug in schizophrenia

This study is completed in the United States, in Romania, in Russia, .... It is testing investigational Drug for schizophrenia.

In United States
SchizophreniaDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States, Romania, Russia, ...
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT00132678

Safety study of safety and Efficacy of Injectable Risperidone in Bipolarity

This study is completed in the United States, in Austria, in India, .... It is testing safety and Efficacy of Injectable Risperidone for Bipolarity.

In United States
BipolarityDrugFrom 18 Years to 65 Years
Countries
United States, Austria, India, ...
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Bipolarity
Drug study icon
CompletedNCT00477672

Safety study of safety and Efficacy of Pimavanserin in Schizophrenia

This study is completed in the United States, in France, in the United Kingdom, .... It is testing safety and Efficacy of Pimavanserin for Schizophrenia.

In United States
SchizophreniaDrugOver 40 Years
Countries
United States, France, United Kingdom, ...
Sponsor
ACADIA Pharmaceuticals Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT04479852

Safety and Efficacy of SP-624 for depression

This study is completed in the United States. It is testing Safety and Efficacy of SP-624 for depression.

In United States
DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Sirtsei Pharmaceuticals, Inc.
Condition
Depression
Drug study icon
CompletedNCT00650611

Safety study of ziprasidone in Schizophrenia

This study is completed in the United States. It is testing ziprasidone for Schizophrenia.

In United States
Schizophrenia, BipolarityDrugFrom 10 Years to 17 Years
Countries
United States
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Schizophrenia, Bipolarity
Drug study icon
CompletedNCT00550238

Safety study of pimavanserin in Schizophrenia

This study is completed in the United States, in France, in Canada, .... It is testing pimavanserin for Schizophrenia.

In United States
SchizophreniaDrugOver 40 Years
Countries
United States, France, Canada, ...
Sponsor
ACADIA Pharmaceuticals Inc.
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.